Naloxone Completed Phase 3 Trials for Malignancies / Pain Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01885182Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain
NCT00412100Oxycodone-naloxone Prolonged Release Tablets in Relieving Opioid-related Constipation
NCT01167127Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
NCT01167699Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain